- Senior Executives at Pfizer, Johnson & Johnson, GlaxoSmithKline, andOther Big Pharma use New Media to Bring Fresh Exchange
Advertisement
PharmaTelevision, the authoritative channel for the pharmaceutical,biotechnology and related industries, announced today the launch of its newservice, PharmaTelevision Premium Content. PTV Premium Content will includePTV News - a daily news and analysis service to be launched in August.Subscription to the service will be free until 30 September, 2009. Dr FintanWalton, CEO of PharmaVentures - the company behind PharmaTelevision - said,"Television captures and delivers something unique, recognising that businessis ultimately about the people in it - whether it's a part of deal making, ordiscovery and development, or about a company's ability to finance itself.It's not a surprise to us that PharmaTelevision has become 'must view' TV formany senior executives and managers".
Advertisement
Dr Walton continues, "Launch of this new service means we can deliver toour subscribers great television programming and integrated news and analysisinformation services." PharmaTelevision addresses the current issues andfuture predictions of the industry, including those of the top companies,through news, analysis, interviews, panels and discussions. Interviewees comefrom companies such as Johnson & Johnson, Merck & Co., sanofi-aventis,Genzyme, MerckSerono, NICE UK, and Roche. As well as PTV News, currentprogrammes include PharmaVentures Business Review; The Regional Report; TheFinancial Report; and PharmaDeals(R) Commentaries, and bring the majorindustry players straight to desktops - on demand from the viewer.
Dr Walton says, "This year, development to PharmaTelevision has beenrapid as we meet the demand from our discerning audience. Our subscribers canlook forward to significant upgrades that help them uncover further value inthe service, and not least will shortly see news services compiled jointly bytop experts from both the pharmaceutical and the television world.Subscribers to PharmaTelevision Premium Content can access over 200 highquality interviews and panel discussions filmed since June 2006. Dr Waltonconcludes, "It's an exciting time for us and our viewers."
About PharmaTelevision(R)
PharmaTelevision (http://www.pharmatelevision.com) is the groundbreakingonline TV channel for the pharmaceutical and biotech sector, offeringinsight, featured interviews, panel discussions and company information.Since May 2006, PharmaTelevision has rapidly grown and the channel now boastsover 200 TV programmes with a truly global audience, 60% of whom are C-suiteexecutives. In 2008, the channel launched a sleek new look and introduced twoexciting TV programmes - the Financial Report and the Regional Report, which,together with our well-established TV programmes, help to give our viewers acomplete overview of industry trends, analysis including deals, investmentsand strategic policies within the sector. In 2009, PharmaTelevision will belaunching PTV News - a daily summary and analysis of the major newsheadlines, ensuring that, wherever in the world they are, our audience canstay truly informed.
Testimonials about the value of PharmaTelevision from industry leadingfigures can be viewed online athttp://www.pharmatelevision.com/VideoHandler.aspx?ID=166&Type=flv
A promotional Video about PharmaTelevision can be viewed online at:http://www.pharmatelevision.com/VideoHandler.aspx?ID=270
PharmaTelevision is a part of the business media division ofPharmaVentures Ltd (http://www.pharmaventures.com).
Notes to Editors:
About PharmaVentures
A leading results driven organisation, PharmaVentures (http://www.pharmaventures.com) assists pharmaceutical and biotechnologycompanies across the world in all aspects of deal making and businessintelligence. The Company's provides tailored consulting and transactionadvisory services to the Life Science industry, with additional deal makingsupport provided through the PharmaDeals range of intelligence products thatinclude analysis tools and reports. An innovative business, PharmaVenturesadditionally provides industry insight through the world's first dedicatedonline pharmaceutical television channel http://www.pharmatelevision.com.
Now in its 17th year PharmaVentures is based in Oxford, UK, employs over50 people mostly educated to PhD or above, and has increased its turnoverfive fold with 80% of revenues from outside the UK. With offices in the USAand Australia, the Company works for a variety of clients from start-ups toglobal corporate pharmaceutical companies.
For further information, or to receive a demonstration of the newservice, please contact:Lisa Holloway Marketing, PharmaTelevision +44-(0)1865-784-177 [email protected] Fintan Walton, +44-(0)1865-784-187 [email protected]
SOURCE PharmaVentures
